Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2008 May 7;46(7):2399–2401. doi: 10.1128/JCM.00024-08

Quadruplex PCR for Simultaneous Detection of Serotype, Biotype, Toxigenic Potential, and Central Regulating Factor of Vibrio cholerae

Hemant Kumar Khuntia 1, Bibhuti Bhusan Pal 1, Guru Prasada Chhotray 1,*
PMCID: PMC2446892  PMID: 18463208

Abstract

A quadruplex PCR was developed for the simultaneous detection of genes specific for Vibrio cholerae O1 and/or O139 serogroup (wbe and/or wbf), cholera toxin A subunit (ctxA), toxin-coregulated pilus (tcpA), and central regulating protein ToxR (toxR) in a single tube reaction. This is a simple, rapid, and accurate approach for the detection of toxigenic V. cholerae O1 and/or O139 and can prevent the rapid spread of the disease by early detection.


Although there are many bacterial causes of diarrhea, only Vibrio cholerae, the etiological agent of cholera, has caused repeated pandemics (15). Of the more than 200 serogroups of V. cholerae identified so far (17), only two serogroups, O1 and O139, are known to cause epidemic and pandemic cholera (6). However, nonepidemic serogroups (non-O1 and non-O139), although not involved in cholera epidemics, can be pathogenic and are occasionally associated with small outbreaks of diarrheal diseases (9). Because untreated cholera leads to the onset of serious outbreaks and potentially great devastation, quick diagnosis and identification of the causative serogroup is necessary from a public health point of view. However, conventional methods of diagnosis are inconvenient for the early detection and characterization of cholera-causing vibrios through a battery of biochemical tests, toxin assay, and slide agglutination with specific antisera (11). In light of the need for quick diagnosis, monoplex PCR and multiplex PCR methods have recently been developed to characterize the serogroup (O1 and/or O139), biotype, toxigenic potential, and association with the regulatory system of V. cholerae strains (1, 5, 7, 4, 13, 15). These approaches are limited in that they do not provide simultaneous detection of the serogroup (O1 or O139), biotype (El Tor or Classical), toxigenic potential, and regulating factor. To address these limitations, we report here on the development of a quadruplex PCR assay that simultaneously targets the wbe (O1) and/or wbf (O139), ctxA, tcpA (El Tor or Classical), and toxR genes.

The targets selected were the wbe (O1) and/or wbf (O139), ctxA, tcpA (El Tor or Classical), and toxR genes. Specific primer pairs were used to identify serotype (O1 or O139) and biotype (O1, Classical, or El Tor). Primer pairs for ctxA (7), tcpA El Tor (7), tcpA Classical (10), wbe (5), wbf (5), and toxR (8) genes were selected from the literature. The quadruplex PCR assay utilizes six primer pairs and detects the presence of wbe (O1) and/or wbf (O139), ctxA, tcpA El Tor or Classical, and toxR genes generating amplification products of 192 and/or 449 bp, 302 bp, 472 or 620 bp, and 901 bp, respectively. Detection of wbe (O1) and/or wbf (O139) confirms the O1 and/or O139 serogroup (5), tcpA confirms whether the sample belongs to either the El Tor (7) or the Classical biotype (10), and toxR demonstrates its involvement in regulating the toxic genes and differentiates it from other vibrios.

For the quadruplex PCR, all of the strains examined by a monoplex PCR, including controls, were grown in Luria-Bertani broth (Difco) at 37°C. As described previously (3), DNA was extracted by boiling the sample for 10 min, followed by storage at −20°C until use. A bacterial cell lysate was used as the source of DNA. To ensure that each individual primer pair was adequate for amplification, a single-target PCR assay was conducted prior to quadruplex PCR optimization with our control strains (Fig. 1). After confirmation of the specificity of each primer by monoplex PCR, we combined primer sets in different ratios and tested the control strains in several PCR cycling protocols. The optimized protocol was carried out with a 35-μl reaction mixture that contained 10× PCR amplification buffer (100 mM Tris [pH 9.0], 500 mM KCl, 0.1% gelatin; Bangalore Genei, India), 2.5 μl of magnesium chloride (25 mM); 2.5 μl each of 2.5 mM dATP, dCTP, dGTP, and dTTP (Bangalore Genei); 90 pmol each primer for tcpA (El Tor) and tcpA (Classical); 68 pmol each primer for ctxA, wbe O1, and wbf O139; 60 pmol primer for toxR; 1.2 U of Taq DNA polymerase (Bangalore Genei); Milli-Q water to a final volume of 29.5 μl; and 5.5 μl of cell lysate (template DNA). Finally, the reaction mixture was overlaid with a drop of sterile mineral oil (Bangalore Genei). Amplification was carried out for 4 min at 94°C for the initial denaturation, followed by 30 cycles of 1.5 min at 94°C, 1.5 min at 55°C, and 1.5 min at 72°C, with a final round of 7 min at 72°C in a thermal cycler (Techne, England). The PCR product (12 μl) was visualized by using a UV transilluminator after electrophoresis in 2% agarose gels in Tris-borate-EDTA buffer at 100 V for 45 min and ethidium bromide staining (0.5 μg/ml).

FIG. 1.

FIG. 1.

Ethidium bromide-stained agarose gel electrophoresis of quadruplex PCR discriminates biotype El Tor from the Classical serogroup and discriminates O1 from O139 and simultaneously detects ctxA and toxR genes. Lane M, 100-bp DNA ladder (Bangalore Genei); quadruplex PCR product, lane 1, ctxA, tcpA, (Classical), toxR, and wbe (O1) gene-positive V. cholerae O1 biotype Classical 569B; lane 2, ctxA, tcpA, (El Tor), toxR, and wbe (O1) gene-positive V. cholerae O1 biotype El Tor strain 20 (VC20); lane 3, JP1; lane 4, Pu1372 (from watery stool); lanes 5 through 7, ctxA, tcpA (El Tor), toxR, and wbf gene-positive V. cholerae O139 strains SG24, KH3, and Pu1416 (from watery stool), respectively; lane 8, ctxA, tcpA, (El Tor), toxR, wbe (O1), and wbf (O139) gene-positive V. cholerae mix infection Pu1442; simplex PCR product, lanes 9 through 14, ctxA, tcpA (El Tor), wbe, wbf, toxR, and tcpA (Classical) genes, respectively; multiplex PCR product, lane 15, ctxA and tcpA (El Tor) gene-positive VC20; lane 16, ctxA and wbe gene-positive VC20; lane 17, ctxA and wbf gene-positive V. cholerae O139 strain SG24; lane 18, ctxA, wbe, and wbf gene-positive V. cholerae mix infection Pu1442; lane M, 100-bp DNA ladder (Bangalore Genei).

To address the specificity of the quadruplex PCR, V. cholerae and strains belonging to the Enterobacteriaceae were subjected for quadruplex PCR (Table 1). Strains of V. cholerae O1, O139, and non-O1/non-O139 were subcultured from the laboratory stocks that had been isolated and confirmed earlier by standard bacteriological methods (16) and a slide agglutination test (3). V. cholerae O1 biotype El Tor strain20, biotype Classical strain 569B, and V. cholerae O139 SG-24 (provided by G. B. Nair, NICED, Kolkata, India) were used as the PCR positive controls for ctxA, wbe (O1), wbf (O139), tcpA El Tor, tcpA Classical, and toxR genes (Fig. 1). The specificity (amplification of a single specific gene) of the quadruplex assay is shown in Fig. 1 with the expected sizes of ctxA, tcpA, wbe O1, wbf O139, and toxR, and PCR products were obtained for all four genes discriminating serogroup O1 from serogroup O139 and biotype Classical from biotype El Tor.

TABLE 1.

Analysis of specificity of the quadruplex PCR using a variety of strains belonging to the families Vibrionaceae and Enterobacteriaceae

Species and serotype CTa production Source No of strains Presence (+) or absence (−) of:
ctxA tcpA (El Tor) wbe (O1) wbf (O139) toxR
V. cholerae O1 Yes Clinical 65 + + + +
V. cholerae O139 Yes Clinical 32 + + + +
V. cholerae O139 No Clinical 3 + + +
V. cholerae O139 Yes Environmental 6 + + + +
V. cholerae non-O1 and non-O139 No Environmental 30 +
V. cholerae non-O1 and non-O139 No Clinical 8 +
V. parahaemolyticus No Clinical 8
Non-vibrio strainsb No Clinical/environmental 52
a

CT, cholera toxin.

b

That is, Salmonella enterica serovar Typhi, clinical (n = 4); Salmonella enterica serovar Paratyphi A, clinical (n = 6); Shigella dysenteriae type 1, clinical (n = 6); Shigella sonnei, clinical (n = 5); enteroinvasive Escherichia coli, clinical (n = 5); enterotoxigenic Escherichia coli, clinical (n = 12); enterohemorrhagic Escherichia coli, clinical (n = 5); Aeromonas hydrophila, clinical (n = 4); and Aeromonas hydrophila, environmental (n = 5).

The sensitivity of our quadruplex PCR assay was examined with 10 representative strains of V. cholerae O1 and O139. To assess the sensitivity of the quadruplex PCR assay, overnight cultures of V. cholerae O1 and O139 strains were suspended in phosphate-buffered saline at a McFarland standard of 1, which is equivalent to 3 × 108 CFU/ml, and were serially diluted 10-fold with sterile phosphate-buffered saline. DNA was extracted from these samples by the method described above and subjected to monoplex PCR. The lower limits of detection (or the minimal number of CFU detectable) of the target genes by quadruplex PCR were calculated. The sensitivity of detection of all target genes for O1 and O139 strains were 1.6 × 103 and 3 × 103 CFU per assay, respectively.

The quadruplex PCR was validated with 30 V. cholerae O1 strains and 10 V. cholerae O139 strains; these strains were confirmed earlier at NICED, Kolkata, India, by a multiplex PCR assay (3). The strains were subjected to quadruplex PCR, and the results were compared to those obtained by monoplex PCR. The quadruplex PCR assay showed 100% specificity in identifying the reference strains; most importantly, nonspecific bands were not visualized. The same results were observed when the DNA of the control V. cholerae strains was included in the quadruplex PCR assay.

To reveal the practical usefulness of the quadruplex PCR assay, 70 and 22 strains of the V. cholerae O1 and O139 strains, respectively, isolated from hospitalized diarrhea patients were compared to those obtained by the monoplex PCR assay. The monoplex and quadruplex PCR assays detected ctxA, tcpA, wbe and/or wbf, and toxR genes among all of the V. cholerae O1 and O139 strains, whereas non-O1 and non-O139 strains carried only the toxR gene. The analysis revealed that there was complete agreement between the results of the monoplex and quadruplex PCR assays for all of the tested strains. All of the non-O1 and non-O139 strains were subjected to repeated PCR assays, and we found that all were positive for the toxR gene.

Our evaluation of the quadruplex PCR assay was conducted from April 2006 to November 2006 with 280 clinical stool samples collected from hospitalized diarrhea patients and 120 environmental water samples from areas of endemicity for cholera in Orissa, India, according to a method described earlier (2, 5). Of the 280 clinical stool and 120 water samples, 62 were positive for V. cholerae (O1, n = 54; O139, n = 8) and 15 were positive for V. cholerae non-O1 and non-O139, by the culture method, with the multiplex and quadruplex PCR assays indicating 100% specificity for our PCR.

Rapid identification and discrimination of O1 and O139 strains is essential for prompt institution of effective antimicrobial chemotherapy and are critical steps in preventing the rapid spread of cholera. Earlier studies have demonstrated the utility of PCR for determining a single gene to detect serotype, biotype, or toxigenic potential (4). Later, one multiplex PCR reported the detection of wbe (O1) and/or wbf (O139) and ctxA (5), while another group reported the presence of tcpA and ctxA (7) and did not show the three genes simultaneously in a single tube reaction. Hexaplex PCR assay (14) detected six genes (ctxA, tcpA, ace, zot, toxR, and sxt) but failed to differentiate the strains belonging to serogroups O1 and O139, which is the prime need in diagnosis. All of these previous investigations failed to amplify four gene targets—ctxA, tcpA, wbe (O1) and/or wbf (O139), and toxR—in a single tube reaction, which requires the performance of a separate PCR. To transcend this limitation, our quadruplex PCR is a successful tool for determining simultaneously the presence of the ctxA gene, the tcpA El Tor and/or Classical gene, the wbe (O1) and/or wbf (O139) gene, and the toxR gene. This one-step quadruplex PCR is a very useful tool for detecting serotype, biotype, toxigenic potential, and regulatory factor in rapid, simple, specific, and accurate manner. Early diagnosis using this technique will hopefully reduce the threat of sudden widespread outbreaks of cholera.

Acknowledgments

This research was supported and funded by ICMR, New Delhi, India, to the Regional Medical Research Center (RMRC), Bhubaneswar, India.

We thank S. K. Kar, RMRC, for his kind support and encouragement and G. B. Nair, National Institute of Cholera and Enteric Diseases, Kolkata, India, for providing V. cholerae standard strains.

Footnotes

Published ahead of print on 7 May 2008.

REFERENCES

  • 1.Albert, M. J., A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, and R. B. Sack. 1993. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 341704. [DOI] [PubMed] [Google Scholar]
  • 2.Chakrobarty, S., J. Khanam, Y. Takeda, and G. B. Nair. 1999. Application of PCR for detection of toxigenic Vibrio cholerae O1 in water samples during an outbreak of cholera. Trans. R. Soc. Trop. Med. Hyg. 93527-528. [DOI] [PubMed] [Google Scholar]
  • 3.Chhotray, G. P., B. B. Pal, H. K. Khuntia, N. R. Chowdhury, S. Chakraborty, S. Yamasaki, T. Ramamurthy, Y. Takeda, S. K. Bhattacharya, and G. B. Nair. 2002. Incidence and molecular analysis of Vibrio cholerae associated with cholera outbreak subsequent to the super cyclone in Orissa, India. Epidemiol. Infect. 18131-138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fields, P. I., T. Popovic, K. Wachsmuth, and Ó. Olsvik. 1992. Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic. J. Clin. Microbiol. 302118-2121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hoshino, K., S. Yamasaki, A. K. Mukhopadhyay, S. Chakraborty, A. Basu, S. K. Bhattacharya, G. B. Nair, T. Shimada, and Y. Takeda. 1998. Development and evaluation of multiplex PCR assays for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS. Immun. Med. Microbiol. 20201-207. [DOI] [PubMed] [Google Scholar]
  • 6.Kaper, J. B., G. Glenn, J. Morris, and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 848-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Keasler, S. P., and R. H. Hall. 1993. Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 3411661. [DOI] [PubMed] [Google Scholar]
  • 8.Miller, V. L., R. K. Taylor, and J. J. Mekalanos. 1987. Cholera toxin transcriptional activator ToxR is a transmembrane DNA-binding protein. Cell 48271-279. [DOI] [PubMed] [Google Scholar]
  • 9.Morris, J. G., Jr. 1990. Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol. Rev. 12179-191. [DOI] [PubMed] [Google Scholar]
  • 10.Rivera, I. N. G., J. Chun, A. Huq, R. B. Sack, and R. R. Colwell. 2001. Genotype associated with virulence in environmental isolates of Vibrio cholerae. Appl. Environ. Microbiol. 672421-2429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sakazaki, R. 1992. Bacteriology of Vibrio cholerae and related organisms, p. 37-55. In D. Barua and W. B. Greenough III (ed.), Cholera. Plenum Medical Book Company, New York, NY.
  • 12.Shi, L., S. Miyoshi, M. Hiura, K. Tomochika, T. Shimada, and S. Shinoda. 1998. Detection of genes encoding cholera toxin (CT), zonnula occludens toxin (ZOT), accessory cholera enterotoxin (ACE) and heat stable enterotoxin (ST) in Vibrio mimicus clinical strains. Microb. Immunol. 42823-828. [DOI] [PubMed] [Google Scholar]
  • 13.Shirai, H., M. Nishibuchi, T. Ramamurthy, S. K. Bhattacharya, S. C. Pal, and Y. Takeda. 1991. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J. Clin. Microbiol. 292517-2521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Singh, D. V., S. R. Isaac, and R. R. Colwell. 2002. Development of a hexaplex PCR assay for rapid detection of virulence and regulating genes in Vibrio cholerae and Vibrio mimicus. J. Clin. Microbiol. 404321-4324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wachsmuth, K., Ø. Olsvik, G. M. Evins, and T. Popovic. 1994. Molecular epidemiology of cholera, p. 357-370. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera. American Society for Microbiology, Washington, DC.
  • 16.World Health Organization. 1987. Manual for laboratory investigations of acute enteric infections. World Health Organization, Geneva, Switzerland.
  • 17.Yamai, S., T. Okitsu, T. Shimada, and Y. Katsube. 1997. Distribution of serogroups of Vibrio cholerae non-O1 and non-O139 with specific reference to their ability to produce cholera toxin and addition of novel serogroups. Kansenshogaku Zasshi 711037-1045. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES